For our final liveblog day we’re back at the Informa Biotech Showcase for more packed panels on AI and funding, a panel on ...

Continued pricing pressures from governments and patient groups are driving small molecule CDMOs to focus on reducing the ...

In today’s pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Isaac Bentwich, CEO and founder of Quris.AI, about ...

The action affects the TROPOS trial of cibotacept (KER-012), an activin signalling inhibitor that works in a similar way to ...

This journey, however, has also revealed the challenges inherent in achieving healthcare equity, particularly in bridging the ...

Eli Lilly has revised its revenue forecast for 2024 after seeing weaker-than-expected growth for its diabetes and obesity ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

With the expiry of multiple biologic patents fast approaching, there is a huge opportunity for the NHS to make further ...

TED is a rare autoimmune disorder in which the muscles and fatty tissues behind the eye become inflamed, causing the eyes to ...

That is the conclusion of a report by the global Commission on Clinical Obesity – published in The Lancet Diabetes and ...

The success of strategies focused on development, change management partnerships, progression flexibility, recognition ...

To encourage the uptake of complex therapies in clinical practice, brand teams must ensure they use data-driven insights to understand the needs and preferences of healthcare professionals (HCPs ...